Prelude Fertility (Prelude) announced today the appointment of seasoned healthcare executive Susan Hertzberg to the role of Chief Executive Officer. Hertzberg joins Prelude from Boston Heart Diagnostics, where she served as President and CEO for six years. Prelude launched in October 2016 as a partnership between Lee Equity Partners, serial entrepreneur Martin Varsavsky, Reproductive Biology Associates (RBA) and My Egg Bank (MEB). It provides proactive fertility care services including egg freezing and storage, genetic testing, donor egg matching, single embryo transfer (SET), as well as traditional in vitro fertilization (IVF).

In her new role, Hertzberg will manage the network expansion of fertility clinics and advance the company’s goal of radically improving fertility choices, care, and outcomes.

“Prelude is growing rapidly and set to innovate how people view and take advantage of advancements in fertility science. Our staff is critical to that growth, and we’re focused on hiring team members with a proven track record of success,” said founder Martin Varsavsky. “Susan is an incredible and dynamic leader with that exact quality and much more. Her strategic vision and wide-ranging talents will help our company achieve tremendous success.”